AstraZeneca (AZN) announced an update on their ongoing clinical study. Study Overview: AstraZeneca is conducting a Phase I study titled ‘A Phase I Randomised, Single-blind, Placebo-controlled Study to ...

AstraZeneca (AZN) announced an update on their ongoing clinical study. AstraZeneca Advances Mid-Stage Rheumatoid Arthritis Trial With AZD1163 Study Overview: AstraZeneca is running a Phase II trial ...

AstraZeneca offers a rare, secular growth profile in biopharma, underpinned by a diversified commercial asset base and layered patent expirations. AZN faces a minor patent cliff, with most key ...

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report ...

Dec 15 (Reuters) - The U.S. Food and Drug Administration has approved AstraZeneca (AZN.L), opens new tab and partner Daiichi Sankyo's (4568.T), opens new tab Enhertu in combination with Roche's (ROG.S ...

Phase III trial involved 594 patients across 20 countries Ceralasertib-Imfinzi combo showed no new safety concerns AstraZeneca shares fall 1% after trial results Dec 22 (Reuters) - AstraZeneca (AZN.L) ...

Details are trickling in about the new manufacturing facility pharmaceutical giant AstraZeneca is building in Albemarle County.

LILONGWE-(MaraviPost)-UTM president Dalitso Kabambe has called for collective action by communities and government to put in ...

Heated Rivalry” star Hudson Williams is pulling back the curtain on his DMs … revealing he’s been getting messages from pro athletes who say they’re still in the closet. Speaking on “Andy Cohen Live,” ...

MIchaelAaron Flicker is the co-author of "Hacking The Human Mind: The Behavioral Science Secrets Behind 17 of the World's ...

After AstraZeneca and Daiichi Sankyo made waves in June with eye-opening results for Enhertu in a combination treatment for a particular type of breast cancer, the companies have scored an FDA ...